Rockefeller Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,000
| Closed | -$18K | – | 2363 |
|
|
2022
Q4 | $18K | Hold |
1,000
| – | – | ﹤0.01% | 2841 |
|
|
2022
Q3 | $19K | Buy |
+1,000
| New | +$19K | ﹤0.01% | 2790 |
|
|
2020
Q1 | – | Sell |
-7,066
| Closed | -$177K | – | 2374 |
|
|
2019
Q4 | $177K | Buy |
7,066
+4,053
| +135% | +$102K | ﹤0.01% | 802 |
|
|
2019
Q3 | $45K | Sell |
3,013
-148
| -5% | -$2.21K | ﹤0.01% | 994 |
|
|
2019
Q2 | $79K | Hold |
3,161
| – | – | ﹤0.01% | 737 |
|
|
2019
Q1 | $72K | Hold |
3,161
| – | – | ﹤0.01% | 834 |
|
|
2018
Q4 | $95K | Hold |
3,161
| – | – | ﹤0.01% | 461 |
|
|
2018
Q3 | $91K | Buy |
+3,161
| New | +$91K | ﹤0.01% | 398 |
|